DRUG DELIVERY FORMULATIONS
The disclosure provides drug delivery formulations that comprise a porous silicon material and a meltable compound, such as a progestin drug, or a meltable composition. The formulations provide for the controlled release of the progestin drug, or other therapeutic agent, over long time periods. In s...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French German |
Published |
29.12.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The disclosure provides drug delivery formulations that comprise a porous silicon material and a meltable compound, such as a progestin drug, or a meltable composition. The formulations provide for the controlled release of the progestin drug, or other therapeutic agent, over long time periods. In some embodiments, the meltable composition further comprises a melting point suppression agent, where the melting point suppression agent enables the loading of thermally unstable therapeutic agents into the porous silicon material by melt casting that would not otherwise be possible absent the melting point suppression agent. The disclosure additionally provides methods of making and using the drug delivery formulations. |
---|---|
AbstractList | The disclosure provides drug delivery formulations that comprise a porous silicon material and a meltable compound, such as a progestin drug, or a meltable composition. The formulations provide for the controlled release of the progestin drug, or other therapeutic agent, over long time periods. In some embodiments, the meltable composition further comprises a melting point suppression agent, where the melting point suppression agent enables the loading of thermally unstable therapeutic agents into the porous silicon material by melt casting that would not otherwise be possible absent the melting point suppression agent. The disclosure additionally provides methods of making and using the drug delivery formulations. |
Author | HOLLETT, Geoffrey Ian SAILOR, Michael J INGALLINERA, Thomas |
Author_xml | – fullname: HOLLETT, Geoffrey Ian – fullname: INGALLINERA, Thomas – fullname: SAILOR, Michael J |
BookMark | eNrjYmDJy89L5WSQcgkKdVdwcfXxDHMNilRw8w_yDfVxDPH09wvmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHG5ubG5sYGjibGRCgBANj-IeI |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | FORMULATIONS D'ADMINISTRATION DE MÉDICAMENT WIRKSTOFFFREISETZUNGSFORMULIERUNGEN |
ExternalDocumentID | EP3773730A4 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP3773730A43 |
IEDL.DBID | EVB |
IngestDate | Fri Nov 08 04:49:30 EST 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP3773730A43 |
Notes | Application Number: EP20190776288 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211229&DB=EPODOC&CC=EP&NR=3773730A4 |
ParticipantIDs | epo_espacenet_EP3773730A4 |
PublicationCentury | 2000 |
PublicationDate | 20211229 |
PublicationDateYYYYMMDD | 2021-12-29 |
PublicationDate_xml | – month: 12 year: 2021 text: 20211229 day: 29 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | The Regents of The University of California |
RelatedCompanies_xml | – name: The Regents of The University of California |
Score | 3.3709745 |
Snippet | The disclosure provides drug delivery formulations that comprise a porous silicon material and a meltable compound, such as a progestin drug, or a meltable... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | DRUG DELIVERY FORMULATIONS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211229&DB=EPODOC&locale=&CC=EP&NR=3773730A4 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTdKSU60TLYErRK31DVJNE7RtUi2MNM1TktJS000BmYvc9BuZF8_M49QE68I0wgmhkzYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dA3szRsAOtIuTrWuAv4u_s5qzM5Cl5hdka2xubgxMzI4mzAyswFa0OSgzuIY5gTalFCDXKG6CDGwBQMPySoQYmFLzhBk4nWEXrwkzcPhC57uBTGjWKxZhkHIJCnVXcHH18QxzDYpUAHbefEN9IJuARRkU3FxDnD10gZbEwz0U7xoAd46xGAMLsJ-fKsGgYGRgbmmWamxkmWaSZAJqOSQZGSSlmSWZW5obGSUnJ0sySOI0RgqPnDQDFyhkQGswjCxlGFhKikpTZYE1aUmSHDgMAOkOdGw |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH9BNOJNUSP4tYPhtkjasdIDMbIWh26wkI3gaWFlS7ggkRn_fV_nQC96e2mTfqW_vvdr33sFuGNkoeZcce0lzk1rThdmV3Vtk2aLLJ1ThBfT0cj-yHYj63nWmVVguY2FKfKEfhbJERFRCvGeF-f1-ucSSxS-lZv7ZIlFbw-DsCdaJTtGNkOQQIt-TwZjMXZajoNSazTpUcYobuZHaw_20cJmGgxy2tdBKevfGmVwDAcBNrbKT6CSrupQc7Yfr9Xh0C_fu1Esobc5haaYRE-GkN5wKievBpI3P_K-g4DPwBjI0HFN7CTeTSiWwW449ByqyPPTCzBIm3E7pYRnVmJpyyEh7SSzE8YZIUqpBjT-bKb5T90t1NzQ92JvOHq5hCO9Stofg_ArqObvH-k1atU8uSnW4wuJBndf |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DRUG+DELIVERY+FORMULATIONS&rft.inventor=HOLLETT%2C+Geoffrey+Ian&rft.inventor=INGALLINERA%2C+Thomas&rft.inventor=SAILOR%2C+Michael+J&rft.date=2021-12-29&rft.externalDBID=A4&rft.externalDocID=EP3773730A4 |